Noah L. Rosenberg - Net Worth and Insider Trading
Noah L. Rosenberg Net Worth
The estimated net worth of Noah L. Rosenberg is at least $3 Million dollars as of 2026-09-06. Noah L. Rosenberg is the Chief Medical Officer of Travere Therapeutics Inc and owns about 47,614 shares of Travere Therapeutics Inc (TVTX) stock worth over $3 Million. Noah L. Rosenberg is also the CMO of Verrica Pharmaceuticals Inc and owns about 8,587 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $45,511. Details can be seen in Noah L. Rosenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Noah L. Rosenberg has not made any transactions after 2026-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Noah L. Rosenberg
Noah L. Rosenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Noah L. Rosenberg owns 3 companies in total, including Travere Therapeutics Inc (TVTX) , Esperion Therapeutics Inc (ESPR) , and Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Noah L. Rosenberg’s form 4 insider trades.
Insider Ownership Summary of Noah L. Rosenberg
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2021-08-17 | Chief Medical Officer |
| ESPR | Esperion Therapeutics Inc | 2013-06-25 | Chief Medical Officer |
| VRCA | Verrica Pharmaceuticals Inc | 2026-08-18 | CMO |
Noah L. Rosenberg Latest Holdings Summary
Noah L. Rosenberg currently owns a total of 2 stocks. Among these stocks, Noah L. Rosenberg owns 47,614 shares of Travere Therapeutics Inc (TVTX) as of August 17, 2021, with a value of $3 Million and a weighting of 98.56%. Noah L. Rosenberg also owns 8,587 shares of Verrica Pharmaceuticals Inc (VRCA) as of August 18, 2026, with a value of $45,511 and a weighting of 1.44%.
Latest Holdings of Noah L. Rosenberg
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2021-08-17 | 47,614 | 65.29 | 3,108,718 |
| VRCA | Verrica Pharmaceuticals Inc | 2026-08-18 | 8,587 | 5.30 | 45,511 |
Holding Weightings of Noah L. Rosenberg
Noah L. Rosenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Noah L. Rosenberg has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the sale of 1,407 shares on August 17, 2021, which brought Noah L. Rosenberg around $24,088.
According to the SEC Form 4 filings, Noah L. Rosenberg has made a total of 2 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 6,230 shares on August 18, 2026, which cost Noah L. Rosenberg around $30,589.
Insider Trading History of Noah L. Rosenberg
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Noah L. Rosenberg Trading Performance
GuruFocus tracks the stock performance after each of Noah L. Rosenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Noah L. Rosenberg is 8.79%. GuruFocus also compares Noah L. Rosenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Noah L. Rosenberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Noah L. Rosenberg's insider trading performs compared to the benchmark.
Performance of Noah L. Rosenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 62.7 |  | | | | |
| Relative Return to S&P 500(%) | 60.24 | | | | | |
Noah L. Rosenberg Ownership Network
Ownership Network List of Noah L. Rosenberg
Ownership Network Relation of Noah L. Rosenberg
Noah L. Rosenberg Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Noah L. Rosenberg is the Chief Medical Officer of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Financial Officer Christopher R. Cline , director & Chief Executive Officer Eric M Dube , and Chief Medical Officer Jula Inrig .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Noah L. Rosenberg made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 140,839 shares made by Elizabeth E Reed , a net sale of 43,322 shares made by Christopher R. Cline , and a net sale of 505,511 shares made by Eric M Dube .
In summary, during the past 3 months, insiders sold 25,142 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 25,142 shares. During the past 18 months, 1,089,113 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,089,113 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Noah L. Rosenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Noah L. Rosenberg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Noah L. Rosenberg's mailing address is: Plymouth Mi 48170.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
